Finland · Delayed Price · Currency is EUR Modulight Oyj Earnings Call Transcripts
Fiscal Year 2026
-
EBITDA and profitability improved despite a 7% revenue decline, driven by strong pipeline growth and increased activity from large customers. The outlook is positive, with guidance for revenue and EBITDA growth, and continued focus on scaling PPT and operational efficiency.
Fiscal Year 2025
-
Record 73% annual sales growth and strong profitability improvements were driven by a diversified customer base, rapid PPT business expansion, and operational efficiencies. Positive cash flow trends and a robust pipeline support continued scaling and strategic focus.
-
Q3 saw revenue surge 176% year-over-year and EBITDA improve 86%, driven by strong growth in the PPT business and a diversified customer base. Operational efficiencies and cost-saving measures are expected to further boost profitability in Q4.
-
Q2 revenue doubled year-over-year, with EBITDA nearing break-even and strong order intake, especially from returning customers. Operational and supplier issues were resolved, and three new major global customers were signed. U.S. tariffs remain a risk, but current impact is minimal.
-
Sales and EBITDA improved significantly year-on-year and sequentially, with revenue up 52% and EBITDA up 56%. Market expansion, new patents, and a strong cash position support a positive outlook, despite regulatory delays and ongoing global uncertainties.
Fiscal Year 2024
-
Q4 saw strong order intake, improved cash flow, and a 40% year-over-year revenue increase, driven by PPT model expansion to over 50 hospitals and operational efficiencies. Most of the order backlog is expected to be delivered this year, supporting the goal of returning to profitable growth.
-
Revenue grew year-on-year to EUR 640,000, with improved but still negative EBITDA and strong cash flow. The pay-per-treatment model and phase III trials are progressing, with order collection up over two-thirds from Q1 to Q3.
-
Q2 revenue declined 22% year-over-year to EUR 965,000, but operational efficiency and cash flow improved after completing the investment program. The R&D pipeline grew to 30 projects, with the PPT model gaining traction and expanded geographic reach, though revenue remains modest due to project delays.